Cargando…
2142. The use of Pseudomonas aeruginosa Phage PASA16 for non resolving infections
BACKGROUND: A growing number of compassionate phage therapy use cases reported in the last decade, with only a limited number of clinical trials conducted and very few unsuccessful clinical trials reported. However, the limited understanding of individual clinical cases and lack of successful publis...
Autores principales: | Onallah, Hadil, Hazan, Ronen, Nir-Paz, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676900/ http://dx.doi.org/10.1093/ofid/ofad500.1765 |
Ejemplares similares
-
Complete Genome Sequence of Pseudomonas aeruginosa Bacteriophage PASA16, Used in Multiple Phage Therapy Treatments Globally
por: Alkalay-Oren, Sivan, et al.
Publicado: (2022) -
Compassionate Use of Bacteriophages for Failed Persistent Infections During the First 5 Years of the Israeli Phage Therapy Center
por: Onallah, Hadil, et al.
Publicado: (2023) -
603. Comparing assays for Clinical Phage Microbiology in biofilm
por: Rimon, Amit, et al.
Publicado: (2022) -
1061. Clinical Phage Microbiology: Evaluating Phages for Biofilm-associated Prosthetic Valve Endocarditis
por: Gelman, Daniel, et al.
Publicado: (2021) -
1690. Assessing the safety of TP-102 bacteriophage treatment in the management of diabetic foot infections
por: Nir-Paz, Ran, et al.
Publicado: (2022)